Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study
Pediatric Rheumatology · 2024
DOI: 10.1186/s12969-024-00976-2 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Pediatric Rheumatology, 2024. Verfasst von Florian Milatz und 21 weiteren Autor:innen. Beteiligte Einrichtung: Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, G…. Hauptthemen laut MEDLINE: Arthritis, Juvenile. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Kinderrheuma-Stiftung, AbbVie Deutschland, Chugai Pharmaceutical.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Physical active lifestyles are essential throughout growth and maturation and may offer potential preventive and therapeutic benefit in patients with juvenile idiopathic arthritis (JIA). Insufficient physical activity (PA), in contrast, can lead to aggravation of disease-related symptoms. This study aimed to i) examine PA levels in children and adolescents with JIA compared to general population controls and ii) investigate correlates of pronounced physical inactivity in order to identify risk groups for sedentary behaviour.
Methods
Data from children and adolescents with JIA and population controls aged 3 to 17 years documented in the National Pediatric Rheumatologic Database (NPRD) and the German Health Interview and Examination Survey for Children and Adolescents (KiGGS) were used. Self-reported PA was collected from parents/guardians of children up to 11 years of age or adolescents 12 years of age and older. To compare PA-related data, age- and sex-specific pairwise analyses were conducted considering NPRD/KiGGS participants' data from 2017. Correlates of physical inactivity among patients were identified using a linear regression model.
Results
Data of 6,297 matched-pairs (mean age 11.2 ± 4.2 years, female 67%, patients’ disease duration 4.5 ± 3.7 years, persistent oligoarthritis 43%) were available for evaluation. Almost 36% of patients aged 3–17 years (vs. 20% of controls) achieved the WHO recommended amount of PA, while PA steadily decreased with age (18% of patients aged ≥ 12 years) and varied between JIA categories. Female adolescents and patients with enthesitis-related arthritis were least likely to achieve the minimum recommended level of PA. Physical inactivity was associated with female sex, higher age at disease onset, longer disease duration, more functional disability (C-HAQ) and higher disease activity (cJADAS-10).
Conclusions
Depending on JIA category, children and adolescents with JIA were similarly or even more likely to achieve the WHO recommended minimum level of PA compared to general population controls. However, since a large proportion of young JIA patients appear to be insufficiently physically active, engagement in targeted efforts to promote PA is urgently needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Germany. florian.milatz@drfz.de.
- Department of Neuropediatrics, Developmental Neurology and Social Paediatrics, University of Tuebingen, Tuebingen, Germany.
- Programme area Epidemiology and Health Services Research, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Germany.
- Department of Paediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, German…
- Programme area Systems Rheumatology, Deutsches Rheuma-Forschungszentrum Berlin, ein Institut der Leibniz-Gemeinschaft, Berlin, Germany.
- Department of Paediatric Pneumology, Allergology and Neonatology, Children's Hospital, Hannover Medical School, Hannover, Germany.
Förderung
- Deutsche Kinderrheuma-Stiftung
- AbbVie Deutschland
- Chugai Pharmaceutical
- GlaxoSmithKline foundation
- Novartis Pharma
- Pfizer
- Deutsches Rheuma-Forschungszentrum Berlin (DRFZ)
Zitieren
APA
Milatz, F., Hansmann, S., Klotsche, J., Niewerth, M., Kallinich, T., Dressler, F., Haas, J. P., Berendes, R., Horneff, G., Hufnagel, M., Weller-Heinemann, F., Windschall, D., Trauzeddel, R., Klaas, M., Girschick, H., Oommen, P. T., Foeldvari, I., Cantez, S. M., Jansson, A. F., …, & Minden, K. (2024). Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study. Pediatric Rheumatology. https://doi.org/10.1186/s12969-024-00976-2
Vancouver
Milatz F, Hansmann S, Klotsche J, Niewerth M, Kallinich T, Dressler F, et al. Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study. Pediatric Rheumatology. 2024. doi:10.1186/s12969-024-00976-2
BibTeX
@article{Milatz2024,
author = {Milatz, Florian and Hansmann, Sandra and Klotsche, Jens and Niewerth, Martina and Kallinich, Tilmann and Dressler, Frank and Haas, Johannes-Peter and Berendes, Rainer and Horneff, Gerd and Hufnagel, Markus and Weller-Heinemann, Frank and Windschall, Daniel and Trauzeddel, Ralf and Klaas, Moritz and Girschick, Hermann and Oommen, Prasad T and Foeldvari, Ivan and Cantez, Serdar Mustafa and Jansson, Annette F and Hartmann, Matthias and Peitz-Kornbrust, Joachim and Minden, Kirsten},
title = {Level and correlates of physical activity among children and adolescents with juvenile idiopathic arthritis compared to controls: results from a German nationwide prospective observational cohort study},
journal = {Pediatric Rheumatology},
year = {2024},
doi = {10.1186/s12969-024-00976-2}
}
EUVIMED